Clinical trial
Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the…
NCT00185042 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00185042 |
|---|---|
| Title | Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of the ACAT Inhibitor CS-505 for Reducing the Progression of Atherosclerosis in Subjects With Coronary Artery Disease Using Intravascular Ultrasound (IVUS) |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Heart Disease |
| Intervention type | Drug |
| Interventions | Pactimibe, CS-505 |
| Enrollment | 534 |
| Start date | Nov 1, 2002 |
| Completion | Jul 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 11, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: